Nifuroxazide inhibits the growth of glioblastoma and promotes the infiltration of CD8 T cells to enhance antitumour immunity
X Wang, J Ye, M Gao, D Zhang, H Jiang… - International …, 2023 - Elsevier
Introduction Glioblastoma is a primary intracranial tumour with extremely high disability and
fatality rates among adults. Existing diagnosis and treatment methods have not significantly …
fatality rates among adults. Existing diagnosis and treatment methods have not significantly …
Nifuroxazide Inhibits the Growth of Glioblastoma and Promotes the Infiltration of Cd8 T Cells to Enhance Antitumour Immunity
XZ Wang, J Ye, M Gao, D Zhang, H Jiang… - Available at SSRN … - papers.ssrn.com
Introduction: Glioblastoma is a primary intracranial tumour with extremely high disability and
fatality rates among adults. Existing diagnosis and treatment methods have not significantly …
fatality rates among adults. Existing diagnosis and treatment methods have not significantly …
Nifuroxazide inhibits the growth of glioblastoma and promotes the infiltration of CD8 T cells to enhance antitumour immunity
X Wang, J Ye, M Gao, D Zhang… - International …, 2023 - pubmed.ncbi.nlm.nih.gov
Introduction Glioblastoma is a primary intracranial tumour with extremely high disability and
fatality rates among adults. Existing diagnosis and treatment methods have not significantly …
fatality rates among adults. Existing diagnosis and treatment methods have not significantly …
Nifuroxazide inhibits the growth of glioblastoma and promotes the infiltration of CD8 T cells to enhance antitumour immunity.
X Wang, J Ye, M Gao, D Zhang, H Jiang… - International …, 2023 - europepmc.org
Methods We explored the potential mechanism of nifuroxazide inhibiting the growth of
glioblastoma cells through in vitro and in vivo experiments. Results nifuroxazide can inhibit …
glioblastoma cells through in vitro and in vivo experiments. Results nifuroxazide can inhibit …